Population pharmacokinetics of ethionamide in patients with tuberculosis
- 1 June 2002
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 82 (2-3) , 91-96
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of Ethionamide Administered under Fasting Conditions or with Orange Juice, Food, or AntacidsAntimicrobial Agents and Chemotherapy, 2001
- Diagnostic Standards and Classification of Tuberculosis in Adults and Children: This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999American Journal of Respiratory and Critical Care Medicine, 2000
- The Effect of Hemodialysis on Cycloserine, Ethionamide, Para-Aminosalicylate, and ClofazimineChest, 1999
- USING THERAPEUTIC DRUG MONITORING TO DOSE THE ANTIMYCOBACTERIAL DRUGSClinics in Chest Medicine, 1997
- Pharmacokinetic Evaluation of Ethionamide SuppositoriesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1991
- Improved high-performance liquid chromatographic assay for the determination of ethionamide in serumJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in manJournal of Antimicrobial Chemotherapy, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976